Trial Search Results
Single Session Class to Reduce Opioid Use in Chronic Pain
Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.
Stanford is currently accepting patients for this trial.
Collaborator: National Institute on Drug Abuse (NIDA)
- Behavioral: Pain Catastrophizing Class
- Behavioral: Health Education
- 18-80 years of age
- Diagnosis of chronic non-cancer pain (> 3 months in duration)
- Currently using prescription opioids ≥ 20mg morphine equivalent daily dose (MEDD) for
≥ 3 months;
- Ability and willingness to complete study procedures.
- Open litigation regarding a medical condition
- Inability to provide informed consent and complete study procedures
- Active suicidality.
Ages Eligible for Study
18 Years - 80 Years
Genders Eligible for Study